A little bit about sphingolipidoses in cardiology: a clinical case of Fabry disease

A little bit about sphingolipidoses in cardiology: a clinical case of Fabry disease

The article presents a clinical case of Fabry disease in a woman, characterized by multisystemic lesions, late onset and predominant clinical picture of heart failure. The features of this pathology are described in detail with an emphasis on instrumental studies of the cardiovascular system, and th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Artyom A. Vedernikov, Evgeny M. Mezhonov, Nikita E. Shirokov, Alexandra M. Adamchuk, Valentina A. Balina, Oleg M. Reitblat, Valentina I. Larionova, Sergey V. Shalaev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2025-01-01
Series:	Терапевтический архив
Subjects:	fabry disease lysosomal storage diseases enzyme replacement therapy left ventricular myocardial hypertrophy -galactosidase lyso-gb3 clinical case
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/636660/203856
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fabry Disease - literature review
by: Krystian Wdowiak, et al.
Published: (2024-11-01)

Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH)
by: K.P. Ng, et al.
Published: (2025-05-01)

Modern Approach to Fabry Disease Diagnosis and Management in Children
by: Olga Ya. Smirnova, et al.
Published: (2024-02-01)

Diagnostics of Fabry disease in arrhythmology practice: a case report
by: M. A. Dragunova, et al.
Published: (2022-08-01)

Comparative pharmacokinetics and pharmacodynamics of two formulations of agalsidase beta (agalsidase Biosidus) and Fabrazyme® by intravenous infusion in healthy male volunteers
by: Viridiana Berstein, et al.
Published: (2024-12-01)

Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey
by: Ari Zimran, et al.
Published: (2025-01-01)

Clinical and pathological features of 10 cases of Fabry’s disease with renal damage
by: HE Juan, et al.
Published: (2020-01-01)

Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors
by: Evelina Maines, et al.
Published: (2025-06-01)

Clinical heterogeneity in Fabry disease
by: G. N. Salogub
Published: (2015-12-01)

Expert review in diagnostic, therapeutic and follow-up of Fabry disease in Latin America based on patient care standards
by: Roberto Giugliani, et al.
Published: (2025-06-01)

Reversing Pathology in an Aggravated Fabry Mouse Model Using Low-Dose Engineered Human Alpha-Galactosidase A AAV Gene Therapy
by: Wanida Ruangsiriluk, et al.
Published: (2025-02-01)

Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
by: Antonino Tuttolomondo, et al.
Published: (2025-03-01)

Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centre
by: Eamon P. McCarron, et al.
Published: (2025-06-01)

Bilateral avascular necrosis: A rare complication of Fabry disease
by: Candela Romano, et al.
Published: (2025-06-01)

Current treatment status of fabry disease in South Korea: a longitudinal National health insurance service data-based study
by: DoHyeon Lee, et al.
Published: (2025-07-01)

Sphingolipidoses and Retinal Involvement: A Comprehensive Review
by: Chiara Carrozzi, et al.
Published: (2025-03-01)

White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up Lesões da substância branca na doença de Fabry antes e depois da terapia de reposição enzimática: um seguimento de 2 anos
by: Laura B. Jardim, et al.
Published: (2006-09-01)

Fabry disease in females: organ involvement and clinical outcomes compared with the general population (103/150 characters)
by: Robert J. Hopkin, et al.
Published: (2025-08-01)

Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology
by: Andrea F. Wise, et al.
Published: (2025-02-01)

Generation of an infantile GM1 gangliosidosis induced pluripotent stem cell line (CHOCi005-A) for disease modeling and therapeutic testing
by: Allisandra K. Rha, et al.
Published: (2024-12-01)

Towards a one‐time cure for Fabry disease: Lentivirus‐mediated haematopoietic stem and progenitor cell gene therapy
by: Rina Kansal
Published: (2025-04-01)

Anderson–Fabry Disease: Focus on Ophthalmological Implications
by: Francesca Giovannetti, et al.
Published: (2024-11-01)

ОПРЕДЕЛИТЬ БОЛЕЗНЬ ФАБРИ
by: Г. П. Арутюнов, et al.
Published: (2013-04-01)

Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease
by: V. I. Ignatyeva, et al.
Published: (2019-01-01)

Fabry Disease: An Update Based on Evidence and Experience
by: J. Politei, et al.
Published: (2025-06-01)

Impaired plasma membrane calcium ATPase activity and mitochondrial dysfunction contribute to calcium dysregulation in Fabry disease-related painful neuropathy
by: Francesco Formaggio, et al.
Published: (2025-09-01)

The unlikely combination: Anderson–Fabry disease and congenital dyserythropoietic anemia type II in a pediatric patient
by: Yasmine Elsherif, et al.
Published: (2024-10-01)

Mutation-Specific Cardiomyocyte Lines from Patients with Fabry Disease: A Sustainable In Vitro Model to Investigate Structure, Function, and Disease Mechanisms
by: Kathleen Nicholls, et al.
Published: (2025-04-01)

Plasma Lyso-PE 22:6 and Lyso-PE 20:4 are associated with development of mild to moderate depression revealed by metabolomics: a pilot study
by: Jingbo Yu, et al.
Published: (2025-07-01)

Cryptogenic strokes and neurological symptoms of Fabry disease
by: Maria Luisa Ruiz-Franco, et al.
Published: (2025-03-01)

Cardiac phenotype of Fabry Disease
by: M. S. Kharlap, et al.
Published: (2018-08-01)

Early identification of cardiac ATTR amyloidosis: a clinical case
by: A. A. Vedernikov, et al.
Published: (2024-07-01)

Fabry Disease: Symptoms in Children and Teenagers
by: L. М. Kuzenkova, et al.
Published: (2015-08-01)

The Role of Kidney Biopsy in Fabry Disease
by: Irene Capelli, et al.
Published: (2025-03-01)

Doença de Fabry e seus Diferentes Fenótipos
by: Murillo Oliveira Antunes, et al.
Published: (2025-03-01)

Fabry disease manifested as nephritis：one case report
by: Wu Feng, et al.
Published: (2022-02-01)

Role of standard echocardiography in Anderson–Fabry disease
by: Maddalena Conte, et al.
Published: (2024-10-01)

А rare case of alcohol septal ablation and cardioverter-defibrillator implantation in patient with Anderson-Fabry disease
by: M. Dimova, et al.
Published: (2025-05-01)

Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders
by: Martina Vinci, et al.
Published: (2025-04-01)

Fabry disease featured by periodic fever and proteinuria:a case report
by: WEN Chu-ling, et al.
Published: (2020-01-01)